Vascular Medicine Flashcards
(47 cards)
Name the factor Xa inhibitors
apixaban (Eliquis)
fondaparinux (Arixtra) - indirect via AT III, renal clearance
rivaroxaban (Xarelto)
Test for Ehler-Danlos
COL1A2 gene mutation in type III procollagen; autosomal dominant
Target HDL, LDL goal in pts w/ PAD
> 40mg/dL
Name the low molecular weight heparins
enoxaparin (Lovenox)
dalteparin (Fragmin)
Pathophys of Loeys Dietz syndrome
Mutations of TGFB, SMAD3
Pathophys, Rx of Marfans
Misfolding of fibrillin, increase in TGFB in heart valves, lung, aorta; beta blockers, ARBs
Rec for ASA s/p PCI
Indefinite
Rec for clopidogrel s/p BMS? DES?
> 1 mo.
> 12 mo.
Most effective monotherapy for hypertriglyceridemia
Fibrates
Test to detect Factor V Leiden
Assay for activated protein C resistance
Serum markers of atheroembolic injury to the kidney
Transient eosinophilia, hypocomplimentemia
Holding instructions for rivaroxaban (Xarelto)
3d before, 2d after
t1/2 = 5-9 hrs
No bridging required
Name the first line treatments for smoking cessation (3)
Nicotine replacement therapy
varenicline (Chantix)
bupropion (Wellbutrin, Zyban)
Method of excretion of direct thrombin inhibitors
Argatroban - hepatobiliary
Lepirudin, bivalirudin - renal, bivalirudin also 80% serum elimination
Half lives of direct thrombin inhibitors
Argatroban 1 hr
Lepirudin 90 min
Bivalirudin 30 min
Name the direct thrombin inhibitors
Hirudin
Bivalirudin
Lepirudin
Argatroban
Dabigatran (pradaxa)
Dx criteria for GCA
3 of 5 Age > 50 New headache Temp artery abnormality ESR >50 Biopsy w/ vasculitis, mononuclear cells, granulomatous inflamm
Goal INR for pt on warfarin and argatroban
4-5, correlates w/ true INR of 2-3; DC argatroban 5 d after starting Coumadin
Contraindications to thrombocytes therapy
Active internal bleeding
Recent (
High risk criteria for bridging off warfarin pre-op
Age >75 Prior vte DM Mech valve Stop warfarin 5d pre-op, therapeutic LMWH for 10d, resume warfarin
Medical mgmt of HIT
Start direct thrombin inhibitor (argatroban), await Plt level of 150k before starting low dose warfarin, dc argatroban after INR >2 (at least 5 days)
Antigenic target of HIT Ab
Heparin-bound PF4
Composition, mechanism of heparin
Mixture of glucosaminoglycans, bind to AT III, factor Xa, resulting in 1000x increase in AT III activity
One year mortality rate for pts w/ CLI
20%